BPC-157 (cytoprotection + VEGF angiogenesis) + TB-500 (G-actin sequestration + cell migration) + GHK-Cu (collagen + matrix induction) co-lyophilized for connective-tissue research
GHK-Cu and Perimenopause: What the Evidence Actually Shows About the Copper Peptide for Skin, Hair, and Collagen Written and edited by Sarah Bonza, MD, MPH, FAAFP, MSCP, DipABLM, NBC-HWC A patient came into my office a few months ago, opened a folder on her phone, and showed me a long list of skincare products she had been cycling through for the past two years
10.1038/nbt.2942 90 LiJ.LinS.VanhoutteP
Sergey Terushkin, MD, FACS Key Takeaways: Mounjaro (tirzepatide) targets GIP + GLP-1 receptors , while Ozempic (semaglutide) targets GLP-1 only Clinical studies show greater average weight loss with tirzepatide in many patients Both medications require BMI 30 or 27 with weight-related conditions Common side effects include nausea, GI discomfort, and appetite changes , usually improving with dose adjustment Insurance coverage varies more common for diabetes than weight loss Prescription required treatment must be doctor-guided and medically supervised If you are deciding between Mounjaro and Ozempic for weight loss in 2026, the key difference is that tirzepatide (Mounjaro) activates two metabolic pathways (GIP + GLP-1), while semaglutide (Ozempic) activates one (GLP-1) which may impact weight loss outcomes and tolerability
Timing and administration details The timing matters more than most people realize
Growth factor upregulation: The peptide stimulates vascular endothelial growth factor (VEGF) production and enhances the expression of growth hormone receptors, promoting angiogenesis and tissue repair
